Prospective study of calcium channel blocker use, cardiovascular disease, and total mortality among hypertensive women: The Nurses' Health Study

Circulation

Volumn 97, Issue 16, 1998, Pages 1540-1548

  Michels, Karin B ^a,b   Rosner, Bernard A ^a   Manson, JoAnn E ^a   Stampfer, Meir J ^a   Walker, Alexander M ^a   Willett, Walter C ^a   Hennekens, Charles H ^a  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b CHANNING LABORATORY   (United States)

Author keywords

Calcium channels; Cardiovascular diseases; Epidemiology; Mortality

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; THIAZIDE DIURETIC AGENT;

ACUTE HEART INFARCTION; ADULT; ANTIHYPERTENSIVE ACTIVITY; ANTIHYPERTENSIVE THERAPY; ARTICLE; CORONARY RISK; FEMALE; HEART MUSCLE ISCHEMIA; HUMAN; HYPERTENSION; INCIDENCE; MAJOR CLINICAL STUDY; MORTALITY; NURSE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SMOKING;

EID: 0032574656     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.97.16.1540     Document Type: Article

References (27)

1. Psaty BM, Heckbert SR, Koepsell TD, Siscovick DS, Raghunathan TE, Weiss NS, Rosendaal FR, Lemaitre RN, Smith NL, Wahl PW, Wagner EH, Furberg CD. The risk of myocardial infarction associated with antihypertensive drug therapies. JAMA. 1995;274:620-625.
2. Jick H, Derby LE, Gurewich V, Vasilakis C. The risk of myocardial infarction associated with antihypertensive drug treatment in persons with uncomplicated essential hypertension. Pharmacotherapy. 1996;16:321-326.
3. Aursnes I, Litleskare I, Frøyland H, Abdelnoor M. Association between various drugs used for hypertension and risk of acute myocardial infarction. Blood Press. 1995;4:157-163.
4. Alderman MH, Cohen H, Roque R, Madhavan S. Effect of long-acting and short-acting calcium antagonists on cardiovascular outcomes in hypertensive patients. Lancet. 1997;349:594-598.
5. Pahor M, Guralnik JM, Corti MC, Foley DJ, Carbonin P, Havlik RJ. Long-term survival and use of antihypertensive medications in older persons. J Am Geriatr Soc. 1995;43:1191-1197.
6. Furberg CD, Psaty BM. Should dihydropyridines be used as first-line drugs in the treatment of hypertension? Arch Intern Med. 1995;155:2157-2161.
7. Walker AM, Stampfer MJ. Observational studies of drug safety. Lancet. 1996;348:489. Letter.
8. Buring JE, Glynn RJ, Hennekens CH. Calcium channel blockers and myocardial infarction: a hypothesis formulated but not yet tested. JAMA 1995;274:654-655.
9. Colditz GA. The Nurses' Health Study: a cohort of US women followed since 1976. J Am Med Womens Assoc. 1995;50:40-44.
10. IHD Register: Report of the Fifth Working Group. Copenhagen. Denmark: World Health Association: 1971.
11. Walker AE, Robins M, Weinfeld FD. The National Survey of Stroke: clinical findings. Stroke. 1981;12(suppl 1):I-13-I-44.
12. Stampfer MJ, Willett WC, Speizer FE, Dysert DC, Lipnick R, Rosner B, Hennekens CH. Test of the National Death Index. Am J Epidemiol. 1984;119:837-839.
13. D' Agostino RB, Lee ML, Belanger AJ, Cupples LA, Anderson K, Kannel WB. Relation of pooled logistic regression to time dependent Cox regression analysis: the Framingham Heart Study. Stat Med. 1990;9:1501-1515.
14. Medical Research Council Working Party. MRC trials of treatment of mild hypertension: principal results. BMJ. 1985;291:97-104.
15. MacMahon S, Peto R, Cutler J, Collins R, Sorlie P, Neaton J, Abbott R, Godwin J, Dyer A, Stamler J. Blood pressure, stroke, and coronary heart disease, I: prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet. 1990;335:765-774.
16. Collins R, Peto R, MacMahon S, Herbert P, Fiebach NH, Eberlein KA, Godwin J, Qizilbash N, Taylor JO, Hennekens CH. Blood pressure, stroke, and coronary heart disease, II: short-term reduction in blood pressure: overview of randomised drug trials in their epidemiological context. Lancet. 1990;335:827-838.
17. Collins R, Peto R. Antihypertensive drug therapy: effects on stroke and coronary heart disease. In: Swales JD, ed. Textbook of Hypertension. Oxford, UK: Blackwell Scientific Publications; 1994:1156-1164.
18. National Disease and Therapeutics Index (NDTI): Diagnosis, I. Ambler, Pa: IMS America Ltd; 1990.
19. Psaty BM, Savage PJ, Tell GS, Polak JF, Hirsch CH, Gardin JM, McDonald RH. Temporal patterns of antihypertensive medication use among elderly patients. JAMA. 1993;270:1837-1841.
20. Manolio TA, Cutler JA, Furberg CD, Psaty BM, Whelton PK, Applegate WB. Trends in pharmacologic management of hypertension in the United States. Arch Intern Med. 1995;155:829-837.
21. Alderman MH. Which antihypertensive drug first - and why! JAMA. 1992;267:2786-2787.
22. 1988 Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. The 1988 report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med. 1988;48:1023-1038.
23. Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. The fifth report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure (JNC V). Arch Intern Med. 1993;153:154-183.
24. Ad Hoc Subcommittee of the Liaison Committee of the World Health Organisation and the International Society of Hypertension. Effects of calcium antagonists on the risks of coronary heart disease, cancer and bleeding. J Hypertens. 1997;15:105-115.
25. New Analyses Regarding the Safety of Calcium Channel Blockers: A Statement for Health Professionals From the National Heart, Lung, and Blood Institute. Rockville, MD: US Dept of Health and Human Services; September 1, 1995.
26. Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. The sixth report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC VI). Arch Intern Med. 1997;157:2413-2446.
27. Staessen JA, Fagard R, Thijs L, Celis H, Arabidze GG, Birkenhäger WH, Bulpitt CJ, de Leeuw PW, Dollery CT, Fletcher AE, Forette F, Leonetti G, Nachev C, O'Brien ET, Rosenfeld J, Rodicio JL, Tuomilehto J, Zanchetti A, for the Systolic Hypertension in Europe (Syst-Eur) Trial Investigators. Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. Lancet. 1997;350:757-764.